+
Site Tour

What are the learnings from the one-year VANTAGE TAVI outcomes in low/intermediate-risk patients?

What can the 1-year VANTAGE data tell us about the future of TAVI in lower-risk patients? Join B. Gonska, H. Dreger, and C. Saint Etienne as they review the latest outcomes, share expert perspectives, and discuss the implications for patient management and clinical decision-making.

MAT-2678890 v1.0

Related Videos

Valvular Heart Disease Guidelines at a Glance

Demonstrated Outcomes. Life-Changing Intervention

Reduced HF Hospitalisation. Improved Quality of Life

Immediate Relief. Durable Benefits

A Defining Moment Has To Start Somewhere. Why Not With You?

Transcatheter tricuspid valve repair: Cases, tips and tricks

M-TEER: Best treatment strategies for FMR AND DMR

TRENDING TOPICS

Reduced HF Hospitalisation. Improved Quality of Life

MitraClip™ TEER Reduces HF Hospitalisations and Improves Patient Outcomes

Demonstrated Outcomes. Life-Changing Intervention

MitraClip™ TEER Delivers Proven Clinical Outcomes Across Diverse Patient Populations

A Defining Moment Has To Start Somewhere. Why Not With You?

A Defining Moment Has To Start Somewhere. Why Not With You?

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline